Prof. Michal Schwartz of the Weizmann Institute of Science, scientific founder of Proneuron, wins Friedenwald Award at the ARVO Meeting.
May 7, 2002

---

NESS ZIONA, Israel,

Proneuron Biotechnologies, Inc. announced today that its scientific founder, Prof. Michal Schwartz, of the Neuroimmunology department at the Weizmann Institute of Science, Israel, has been granted the Friedenwald Award by the Association for Research in Vision and Ophthalmology (ARVO), "for pioneering work in the area of optic nerve recovery after injury". Prof. Schwartz's studies on the neurodegenerative and neuroprotective aspects of glaucoma have demonstrated that progression of glaucoma and various other neurodegenerative disorders can be attenuated via therapeutic vaccination. Proneuron Biotechnologies supports Prof. Schwartz's research and holds rights to technology derived from it. The development of a proprietary therapeutic vaccine for acute and chronic neurodegenerative disorders is currently in advanced preclinical development for several indications.

Editor's Note
Proneuron Biotechnologies Inc., based in Ness-Ziona, Israel, is a privately held biopharmaceutical company developing products for the treatment of spinal cord injuries and other acute and chronic disorders of the central nervous system based on proprietary technology for modulating the interaction between the nervous and the immune systems. See http://www.proneuron.com for more information.

Contact: Nir Nimrodi, CEO
Tel. +972-8-9409550
Email: nir.nimrodi@proneuron.com

The Weizmann Institute of Science, in Rehovot, Israel, is one of the world's foremost centers of scientific research and graduate study. Its 2,500 scientists, students, technicians, and engineers pursue basic research in the quest for knowledge and the enhancement of humanity. New ways of fighting disease and hunger, protecting the environment, and harnessing alternative sources of energy are high priorities at the Weizmann Institute of Science.

Contact: Yivsam Azgad, Spokesman,
Tel. +972-8-934-3856
Email: Yivsam.Azgad@weizmann.ac.il, News@Weizmann.ac.il